Home / Insights / Hatchtech Pty Ltd to explore strategic alternatives for commercialization of Xeglyze™ lotion in the U.S.

Hatchtech Pty Ltd to explore strategic alternatives for commercialization of Xeglyze™ lotion in the U.S.

26 March 2015

Posted in — OneVentures

Share

Learn More

Share

You may also like

02 August 2020

Healthcare

FDA Approves Xeglyze™ for the topical treatment of head lice infestation


02 August 2020

Healthcare

Hatchtech gets lice treatment nod from FDA


01 February 2018

OneVentures

No nit picking: Head lice group Hatchtech gets green light to trials


View All

Ventured. Gained.
decor